Loading
 สักการ สังฆมานนท์

สักการ สังฆมานนท์

ภาควิชาพยาธิวิทยา,
คณะแพทยศาสตร์,
มหาวิทยาลัยขอนแก่น

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma Chua-On, D
Proungvitaya, T
Techasen, A
Limpaiboon, T
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sungkhamanon, S
Proungvitaya, S
2016
2. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells Dokduang, H
Yongvanit, P
Namwat, N
Pairojkul, C
Sangkhamanon, S
Yageta, MS
Murakami, Y
Loilome, W
2016
3. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. Supak Yothaisong
Hasaya Dokduang
Naohiko Anzai
Keitaro Hayashi
Nisana Namwat
Puangrat Yongvanit
Sakkarn Sangkhamanon
Promsuk Jutabha
Hitoshi Endou
Watcharin Loilome
2017
4. MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma Kulyada Somsap
Nittaya Chamadol
Attapol Titapun
Chawalit Pairojkul
Sakkarn Sangkhamanon
2017
5. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. Sureerat Padthaisong
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Aekkaphod Liwatthakun
Khittisak Hankla
Sakkarn Sangkhamanon
Watcharin Loilome
2017
6. Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma Sangkhamanon, S
Jongpairat, P
Sookprasert, A
Wirasorn, K
Titapun, A
Pugkhem, A
Ungareevittaya, P
Chindaprasirt, J
2017
7. Targeting hexokinase II as a possible therapy for cholangiocarcinoma Thamrongwaranggoon, U
Seubwai, W
Phoomak, C
Sangkhamanon, S
Cha'on, U
Boonmars, T
Wongkham, S
2017
8. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Nattaporn Phanthaphol
Anchalee Techasen
Watcharin Loilome
Suyanee Thongchot
Raynoo Thanan
Sakkarn Sungkhamanon
Narong Khuntikeo
Puangrat Yongvanit
Nisana Namwat
2017
9. Biopsy Global Grade Group vs. Highest Grade Group vs. Largest Volume Cancer Grade Group: Concordance of Biopsy 'Case Level' and Radical Prostatectomy Grade Groups Kiril Trpkov
Sakkarn Sangkhamanon
Asli Yilmaz
Shaun Medlicott
Panche Zdravkovski
Tarek Bismar
Melissa A. Shea-Budgell
2018
10. Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature. Sirithanaphol, W
Sangkhamanon, S
Netwijitpan, S
Foocharoen, C
2018
11. Concordance of "Case Level" Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy. Kiril Trpkov
Sakkarn Sangkhamanon
Asli Yilmaz
Shaun A. C. Medlicott
Bryan Donnelly
Geoffrey Gotto
Melissa Shea-Budgell
2018
12. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth Padthaisong, S
Dokduang, H
Yothaisong, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Sangkhamanon, S
Loilome, W
2018
13. Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018
14. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. Kittirat, Y
Techasen, A
Thongchot, S
Loilome, W
Thanan, R
Yongvanit, P
Sungkhamanon, S
Titapun, A
Khuntikeo, N
Namwat, N
2018
15. Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine Yingpinyapat Kittirat
Anchalee Techasen
Suyanee Thongchot
Watcharin Loilome
Raynoo Thanan
Puangrat Yongvanit
Sakkarn Sungkhamanon
Attapol Titapun
Narong Khuntikeo
Nisana Namwat
2018
16. Gleason Grading: Clear and Straightforward Rules Facilitate Judgment. Trpkov, K
Yilmaz, A
Sangkhamanon, S
Medlicott, S
Donnelly, B
Gotto, G
Shea-Budgell, M
2019
17. Infantile cardiac hemangioma causing right ventricular inflow obstruction. Karunasumetta, C
Wongbhuddha, C
Sangkhamanon, S
Mokarat, B
2019
18. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma Doungdean Tummanatsakun
Tanakorn Proungvitaya
Sittiruk Roytrakul
Temduang Limpaiboon
Sopit Wongkham
Chaisiri Wongkham
Atit Silsirivanit
Ongart Somintara
Sakkarn Sangkhamanon
Siriporn Proungvitaya
2019
19. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. Surangkana Sanmai
Tanakorn Proungvitaya
Temduang Limpaiboon
Daraporn Chua-On
Wunchana Seubwai
Sittiruk Roytrakul
Sopit Wongkham
Chaisiri Wongkham
Ongart Somintara
Sakkarn Sangkhamanon
Siriporn Proungvitaya
2019
20. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma Padthaisong, S
Thanee, M
Namwat, N
Phetcharaburanin, J
Klanrit, P
Khuntikeo, N
Titapun, A
Sungkhamanon, S
Saya, H
Loilome, W
2020
Count 0 14 15 0

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 รวม

Title Authors Year Journal title
1. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. Dokduang, H
Yongvanit, P
Namwat, N
Pairojkul, C
Sangkhamanon, S
Yageta, MS
Murakami, Y
Loilome, W
2016 Oncology reports
4 (35), pp. 2065-72
2. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. Chua-On, D
Proungvitaya, T
Techasen, A
Limpaiboon, T
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sungkhamanon, S
Proungvitaya, S
2016 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (37), pp. 13659-13667
3. Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma Sangkhamanon, S
Jongpairat, P
Sookprasert, A
Wirasorn, K
Titapun, A
Pugkhem, A
Ungareevittaya, P
Chindaprasirt, J
2017 Asian Pacific journal of cancer prevention : APJCP
6 (18), pp. 1671-1674
4. Targeting hexokinase II as a possible therapy for cholangiocarcinoma. Thamrongwaranggoon, U
Seubwai, W
Phoomak, C
Sangkhamanon, S
Cha'on, U
Boonmars, T
Wongkham, S
2017 Biochemical and biophysical research communications
2 (484), pp. 409-415
5. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. Yothaisong, S
Dokduang, H
Anzai, N
Hayashi, K
Namwat, N
Yongvanit, P
Sangkhamanon, S
Jutabha, P
Endou, H
Loilome, W
2017 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
3 (39), pp. 1010428317694545
6. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. Padthaisong, S
Thanee, M
Techasen, A
Namwat, N
Yongvanit, P
Liwatthakun, A
Hankla, K
Sangkhamanon, S
Loilome, W
2017 Anticancer research
7 (37), pp. 3591-3597
7. Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature. Sirithanaphol, W
Sangkhamanon, S
Netwijitpan, S
Foocharoen, C
2018 Journal of endourology case reports
1 (4), pp. 91-93
8. Concordance of "Case Level" Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy. Trpkov, K
Sangkhamanon, S
Yilmaz, A
Medlicott, SAC
Donnelly, B
Gotto, G
Shea-Budgell, M
2018 The American journal of surgical pathology
11 (42), pp. 1522-1529
9. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. Kittirat, Y
Techasen, A
Thongchot, S
Loilome, W
Thanan, R
Yongvanit, P
Sungkhamanon, S
Titapun, A
Khuntikeo, N
Namwat, N
2018 Oncology letters
1 (15), pp. 347-353
10. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. Padthaisong, S
Dokduang, H
Yothaisong, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Sangkhamanon, S
Loilome, W
2018 Oncology letters
2 (16), pp. 1627-1633
11. Infantile cardiac hemangioma causing right ventricular inflow obstruction. Karunasumetta, C
Wongbhuddha, C
Sangkhamanon, S
Mokarat, B
2019 Asian cardiovascular & thoracic annals
(), pp. 218492319836899
12. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. Sanmai, S
Proungvitaya, T
Limpaiboon, T
Chua-On, D
Seubwai, W
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sangkhamanon, S
Proungvitaya, S
2019 Oncology letters
6 (17), pp. 5275-5282
13. Gleason Grading: Clear and Straightforward Rules Facilitate Judgment. Trpkov, K
Yilmaz, A
Sangkhamanon, S
Medlicott, S
Donnelly, B
Gotto, G
Shea-Budgell, M
2019 The American journal of surgical pathology
2 (43), pp. 291-292
14. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. Padthaisong, S
Thanee, M
Namwat, N
Phetcharaburanin, J
Klanrit, P
Khuntikeo, N
Titapun, A
Sungkhamanon, S
Saya, H
Loilome, W
2020 Journal of translational medicine
1 (18), pp. 64

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma Daraporn Chua-on
Tanakorn Proungvitaya
Anchalee Techasen
Temduang Limpaiboon
Sittiruk Roytrakul
Sopit Wongkham
Chaisiri Wongkham
Ongart Somintara
Sakkarn Sungkhamanon
Siriporn Proungvitaya
2016 TUMOR BIOLOGY
10.0 (37.0), pp. 13659.0-13667.0
17 0 0 0 0 0 17
2. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells Hasaya Dokduang
Puangrat Yongvanit
Nisana Namwat
Chawalit Pairojkul
Sakkarn Sangkhamanon
Mika Sakurai Yageta
Yoshinori Murakami
Watcharin Loilome
2016 ONCOLOGY REPORTS
4.0 (35.0), pp. 2065.0-2072.0
24 0 0 0 0 0 24
3. Inhibition of L-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment Supak Yothaisong
Hasaya Dokduang
Naohiko Anzai
Keitaro Hayashi
Nisana Namwat
Puangrat Yongvanit
Sakkarn Sangkhamanon
Promsuk Jutabha
Hitoshi Endou
Watcharin Loilome
2017 TUMOR BIOLOGY
3.0 (39.0), pp.
19 0 0 0 0 0 19
4. MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma Kulyada Somsap
Nittaya Chamadol
Attapol Titapun
Chawalit Pairojkul
Sakkarn Sangkhamanon
2017 BJR CASE REPORTS
1.0 (3.0), pp.
0 0 0 0 0 0 0
5. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process Sureerat Padthaisong
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Aekkaphod Liwatthakun
Khittisak Hankla
Sakkarn Sangkhamanon
Watcharin Loilome
2017 ANTICANCER RESEARCH
7.0 (37.0), pp. 3591.0-3597.0
14 0 0 0 0 0 14
6. Targeting hexokinase II as a possible therapy for cholangiocarcinoma Ubonrat Thamrongwaranggoon
Wunchana Seubwai
Chatchai Phoomak
Sakkarn Sangkhamanon
Ubon Cha'on
Thidarat Boonmars
Sopit Wongkham
2017 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2.0 (484.0), pp. 409.0-415.0
15 0 0 0 0 0 15
7. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Nattaporn Phanthaphol
Anchalee Techasen
Watcharin Loilome
Suyanee Thongchot
Raynoo Thanan
Sakkarn Sungkhamanon
Narong Khuntikeo
Puangrat Yongvanit
Nisana Namwat
2017 ONCOLOGY LETTERS
5.0 (14.0), pp. 5973.0-5979.0
4 0 0 0 0 0 4
8. Biopsy Global Grade Group vs. Highest Grade Group vs. Largest Volume Cancer Grade Group: Concordance of Biopsy 'Case Level' and Radical Prostatectomy Grade Groups Kiril Trpkov
Sakkarn Sangkhamanon
Asli Yilmaz
Shaun Medlicott
Panche Zdravkovski
Tarek Bismar
Melissa A. Shea-Budgell
2018 MODERN PATHOLOGY
(31.0), pp. 394.0-394.0
0 0 0 0 0 0 0
9. Concordance of Case Level Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy Kiril Trpkov
Sakkarn Sangkhamanon
Asli Yilmaz
Shaun A. C. Medlicott
Bryan Donnelly
Geoffrey Gotto
Melissa Shea-Budgell
2018 AMERICAN JOURNAL OF SURGICAL PATHOLOGY
11.0 (42.0), pp. 1522.0-1529.0
14 0 0 0 0 0 14
10. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapol Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018 ONCOLOGY LETTERS
2.0 (16.0), pp. 1627.0-1633.0
3 0 0 0 0 0 3
11. Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 745.0-745.0
0 0 0 0 0 0 0
12. Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine Yingpinyapat Kittirat
Anchalee Techasen
Suyanee Thongchot
Watcharin Loilome
Raynoo Thanan
Puangrat Yongvanit
Sakkarn Sungkhamanon
Attapol Titapun
Narong Khuntikeo
Nisana Namwat
2018 ONCOLOGY LETTERS
1.0 (15.0), pp. 347.0-353.0
8 0 0 0 0 0 8
13. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma Doungdean Tummanatsakun
Tanakorn Proungvitaya
Sittiruk Roytrakul
Temduang Limpaiboon
Sopit Wongkham
Chaisiri Wongkham
Atit Silsirivanit
Ongart Somintara
Sakkarn Sangkhamanon
Siriporn Proungvitaya
2019 BIOMOLECULES
9.0 (9.0), pp.
1 0 0 0 0 0 1
14. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma Surangkana Sanmai
Tanakorn Proungvitaya
Temduang Limpaiboon
Daraporn Chua-On
Wunchana Seubwai
Sittiruk Roytrakul
Sopit Wongkham
Chaisiri Wongkham
Ongart Somintara
Sakkarn Sangkhamanon
Siriporn Proungvitaya
2019 ONCOLOGY LETTERS
6.0 (17.0), pp. 5275.0-5282.0
2 0 0 0 0 0 2
15. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma Sureerat Padthaisong
Malinee Thanee
Nisana Namwat
Jutarop Phetcharaburanin
Poramate Klanrit
Narong Khuntikeo
Attapol Titapun
Sakkarn Sungkhamanon
Hideyuki Saya
Watcharin Loilome
2020 JOURNAL OF TRANSLATIONAL MEDICINE
1.0 (18.0), pp.
0 0 0 0 0 0 0

Title Authors Year Journal title

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ

0.01756453514099121